Aethlon Medical Expands Highly Dilutive ATM Program, May Sell $542K More Shares

summarizeSummary

Aethlon Medical is expanding its existing At-The-Market (ATM) offering, allowing it to sell up to an additional $542,716 in common stock, adding to the $1.85 million already sold under the program, to address its "going concern" warning.

check_boxKey Events · Financing and Capital Events · AEMD

• Expanded ATM Offering

  The company filed an amendment to its At-The-Market (ATM) prospectus, authorizing the sale of up to an additional $542,716 in common stock.

• Significant Prior Sales

  This new authorization follows the sale of $1,849,457 worth of securities under the same ATM program prior to this amendment.

• High Dilution

  The total amount raised and authorized for sale under this ATM program ($2.39 million) represents approximately 72.6% of the company's current market capitalization.

• Going Concern Context

  This capital raise is critical for the company, which previously issued a "going concern" warning due to insufficient cash for the next 12 months.

auto_awesomeAnalysis · AEMD · Industrial Applications And Services

Aethlon Medical, facing a "going concern" warning, has updated its At-The-Market (ATM) offering program, authorizing the sale of up to an additional $542,716 in common stock. This follows prior sales of $1.85 million under the same program. The combined potential and actual sales represent a significant portion of the company's current market capitalization, indicating substantial dilution for existing shareholders as the company seeks to extend its cash runway. The offering price for the public float calculation ($3.07) is significantly higher than the current stock price ($2.05), suggesting that future sales will be at a lower price, increasing the dilutive impact.